Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA) is a healthcare company (biotechnology) based in the United States. The share price is $26.20, down 2.86% on the day, which values the company at $1.89B. Price as of 18 Nov 2026, 11:56 UTC, from Yahoo Finance.

Key facts

Share price
$26.20−2.86% today
Market value
$1.89B
200-week average
$29.2310% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Vera Therapeutics, Inc. in more detail

VERA trades at -6.7× next year's expected earnings, 184.3× sales. It sits 10% below its 200-week average of $29.23.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Vera Therapeutics, Inc. (VERA): questions and answers

What is Vera Therapeutics, Inc.'s market cap?

Vera Therapeutics, Inc. is valued at $1.89B at a share price of $26.20.

Is VERA above its 200-week moving average?

No. VERA is 10.4% below its 200-week average of $29.23. Long-term investors watch that line because strong companies rarely trade below it for long.

Does VERA pay a dividend?

Vera Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Vera Therapeutics, Inc. (VERA) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/VERA

Underlying data: Yahoo Finance; company filings with the SEC.